Cargando…
Comprehensive RNA-Seq Analysis of Potential Therapeutic Targets of Gan–Dou–Fu–Mu Decoction for Treatment of Wilson Disease Using a Toxic Milk Mouse Model
Background: Gan–Dou–Fu–Mu decoction (GDFMD) improves liver fibrosis in experimental and clinical studies including those on toxic mouse model of Wilson disease (Model). However, the mechanisms underlying the effect of GDFMD have not been characterized. Herein, we deciphered the potential therapeutic...
Autores principales: | Wei, Taohua, Hao, Wenjie, Tang, Lulu, Wu, Huan, Huang, Shi, Yang, Yue, Qian, Nannan, Liu, Jie, Yang, Wenming, Duan, Xianchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082393/ https://www.ncbi.nlm.nih.gov/pubmed/33935715 http://dx.doi.org/10.3389/fphar.2021.622268 |
Ejemplares similares
-
System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease
por: Zhang, Juan, et al.
Publicado: (2021) -
GanDouLing promotes proliferation and differentiation of neural stem cells in the mouse model of Wilson’s disease
por: Dong, Ting, et al.
Publicado: (2021) -
Role of serum ceruloplasmin in the diagnosis of Wilson's disease: A large Chinese study
por: Yang, Yue, et al.
Publicado: (2022) -
GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson’s disease
por: Chen, Yonghua, et al.
Publicado: (2018) -
Dysfunction of the Lenticular Nucleus Is Associated with Dystonia in Wilson’s Disease
por: Yang, Yulong, et al.
Publicado: (2022)